Progyny Business Model Canvas

Progyny integrates with major national health plans and TPAs (third-party administrators) to streamline claims and eligibility; by 2025 Progyny reported partnerships covering over 1,200 employer health plans and processed claims for ~320,000 members, making fertility benefits appear as part of core coverage rather than a silo. This technical and operational alignment cuts administrative friction, lowering claim denial rates and speeding authorizations for employers and members.

Progyny's key partners-select high-volume clinics, Mercer/Willis/Aon brokers, 1,200+ health plans/TPAs, pharma/PBM via Progyny Rx, specialty pharmacies, and advocacy groups-drove quality care, network expansion (12 new metros by 2025), ~68% member-cycle coverage (2024), $280M enterprise revenue (2024) with ~45% from broker alliances, ~30% lower member OOP drug spend (2025), and ~320k members served.

Progyny uses proprietary data from >100,000 fertility cycles to measure clinical outcomes and a reported 65% reduction in total per-pregnancy medical spend for participating employers, delivering ROI reports that show payback within 12-24 months for many clients.

By analyzing trends across thousands of cycles, Progyny refines its Smart Cycle care pathways and provides predictive insights-such as projected live-birth uplift and cost-per-live-birth-critical for CFOs and HR to justify the benefit.

Progyny runs a vetted provider network (SET >75%, multiple-births <5% vs US ~23% in 2024), Patient Care Advocates (20-30% higher success, 25% lower dropout; cost ~$1,200-$2,000/member), proprietary data from >100,000 cycles (65% reduction in per-pregnancy spend; ROI 12-24 months), $58M IT/R&D FY2024, telehealth/AI 35% consults, membership 165,000 (+18% YoY).

Progyny holds one of the largest fertility-treatment outcome datasets-covering >200,000 cycles and published in peer-reviewed journals-that benchmarks provider performance and demonstrates its model's higher pregnancy and live-birth rates (reported ~20-30% relative lift in select cohorts). This proprietary data is costly to replicate, creating a clinical-authority moat that supports marketing, R&D, and sustained payer and employer contracts.

Progyny's key resources: Proprietary Smart Cycle Model (38% higher live-births, 22% lower per-pregnancy spend since 2024), Patient Care Advocates (>90% satisfaction, ~15% fewer cancellations, 120h training), 200k+ cycle outcomes dataset, brand serving 1,300+ employers and $637M revenue (2024), platform saving $18M admin costs and 40% faster claims; HIPAA/GDPR compliant, 6 languages (2025), 10× scalability.

By cutting high-risk multiple births-Progyny reports twin+ rates under 5% vs ~30% with traditional IVF-employers avoid costly NICU and maternal claims (NICU average stay cost ~$76,000 in 2024) and lower long-term spend; Progyny's integrated pharmacy benefit reduced drug waste and drove per-member per-year savings of $2,300 in client case studies (2023-2025), boosting productivity through fewer leave days and lower medical claims.

Progyny raises live-birth-per-cycle ~24% and cuts twin+ births to <5% (2020-2024), yielding ~$12,000 medical savings per pregnancy and $2,300 PMPY drug savings (2023-2025); 68% members report less stress and employers saw 12% higher retention and 25% lower absenteeism (2024).

Progyny keeps clinics engaged by streamlining admin workflows and offering 7-10 day payment cycles, reducing claim reconciliation time by 30% and driving a 12% higher appointment availability for members in 2024.

Progyny combines high-touch Patient Care Advocates with 24/7 self – service, driving 92% member satisfaction, 23% faster time – to – treatment, ~30% lower support load, +22% trust, -12% claims disputes, 15% higher service use and 22% employer spend reduction (all reported 2024).

By embedding Progyny services into national carriers' plans, Progyny accesses ~60% more small-employer lives and appeals to employers preferring bundled benefits; integrated billing cuts implementation time by ~30% and drove a 2024 channel revenue increase of 18% for carriers partnering on fertility benefits, making this channel a high-leverage route for national market expansion.

Enterprise sales, benefit consultants, carrier embeds, member app, and events drive Progyny growth: enterprise ARR +28% (2024), consultants influenced ~65% of decisions, carrier embeds +18% channel revenue (2024), 46,000+ providers, 50% cycles via specialty pharmacy, 79% member satisfaction, 14% higher cycle success; events drove +22% inbound leads (post-2024) and 18 deals (2025 YTD).

Government agencies, school districts, and labor unions-each with collective bargaining and custom benefit rules-make up a specialized Progyny segment; Progyny reported serving public-sector clients that accounted for about 18% of revenue in 2024, reflecting steady contract wins. Progyny adapts care bundles and eligibility rules for diverse, often aging workforces, and multi-year public contracts yield predictable, long-term revenue streams and lower churn.

Large self-insured employers (5,000+ employees) drive ~65% enterprise revenue; mid-market (500-5,000) is growth target (3-7% penetration → $50-120M ARR); public sector ~18% revenue; carriers/channel ~35% revenue; ~220,000 members served in 2024; avg member age 35.8; avg claim ~$12,000 per cycle.

Sales and marketing for Progyny incur high front-loaded costs-sales commissions, targeted campaigns, and industry events-averaging $18k-$30k to acquire an enterprise client in 2024, with payback often 12-24 months; maintaining brand share in the crowded fertility benefits market adds recurring spend (~10-15% of revenue in marketing at scale).

Major costs: personnel $223M (2024, ~45% OpEx), platform R&D/capex $85-95M (2024, ~18-20% revenue), G&A $173.6M (FY2024, ~28% OpEx), provider network $18-22M (2024), marketing CAC $18-30k per enterprise client (payback 12-24 months); international compliance +15-25% over 3 years.

Progyny charges employers a per-employee-per-month (PEPM) administrative fee-a predictable subscription-style revenue stream that covered ~60% of revenue for fertility benefit managers in 2024; typical PEPMs range $3-$20 depending on plan scope and employer size, and are paid monthly regardless of individual utilization, funding the advocacy platform, case management, and member support.

Progyny's 2024 revenue mix: ~60% utilization-based medical services (Smart Cycle avg $15,000; network services +$4,000 per episode), ~18% Progyny Rx pharmacy (lifted FY2024 revenue to $420M; drug capture +22% vs 2022), PEPM admin fees $3-$20 covering ~60% of typical benefit-manager revenue, setup fees <5% ARR (example $150k for 5,000 employees), analytics add-ons +35% YoY.